Showing 821-830 of 2689 results for "".
Onabotulinumtoxin A for Headache: An Update
https://practicalneurology.com/diseases-diagnoses/headache-pain/onabotulinumtoxin-a-for-headache-an-update/30783/A year after FDA approval, a specialist offers an update on neurotoxin therapy for migraine and headache.Sexual Discomfort: Dealing with Dysfunction in MS and Other Neurological Conditions
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN0509_01-php/30915/Sexual dysfunction can be detrimental to patients with neurodegenerative disease—especially MS. So why aren't patients—and neurologists—talking more about it?Board Re-Certification: Reform or Reboot
https://practicalneurology.com/columns/practice-management/board-re-certification-reform-or-reboot/30542/A neurologist has been leading the charge to reform MOC in neurology. He talked to Practical Neurology® about the issue.Hemicrania Continua: A Question and Answer Review
https://practicalneurology.com/diseases-diagnoses/headache-pain/hemicrania-continua-a-question-and-answer-review/30785/A headache specialist explores the incidence, diagnosis, and treatment of this frequently misdiagnosed headache type.Spinal Cord Infarct: Clinical & Imaging Pearls
https://practicalneurology.com/diseases-diagnoses/imaging-testing/spinal-cord-infarct-clinical--imaging-pearls/30394/Rising Drug Prices and the Cost of Care: What Can Physicians Do?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/rising-drug-prices-and-the-cost-of-care-what-can-physicians-do/30327/The multiple sclerosis drug market offers a snapshot of a growing problem. Physicians should speak out on behalf of the specialty and their patients.Preferred Treatment: The Changing Economics of Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/preferred-treatment-the-changing-economics-of-multiple-sclerosis-care/30486/By deciding which drugs are “preferred,” insurance companies are reducing the practice of evidence-based medicine to a series of economic choices.NeuroAdvocacy: Why Lobbying Matters
https://practicalneurology.com/columns/practice-management/neuroadvocacy-why-lobbying-matters/30328/Advocating for patients and the specialty is a powerful way for physicians to make their voices heard.Confronting the Clinical Challenges of Frontotemporal Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/confronting-the-clinical-challenges-of-frontotemporal-dementia/30848/A look at FTD's symptoms, pathophysiology, subtypes, as well as the latest from imaging studies.Filling the Gap in Pediatric Neurology
https://practicalneurology.com/diseases-diagnoses/child-neurology/filling-the-gap-in-pediatric-neurology/30265/The view from an area without pediatric neurologists.